Articles

The gene signature in CCAAT-enhancer-binding protein α dysfunctional acute myeloid leukemia predicts responsiveness to histone deacetylase inhibitors

Cancer Science Institute, National University of Singapore, Singapore;University of Michigan, Ann Arbor, MI, USA
Cancer Science Institute, National University of Singapore, Singapore
Institute of Molecular Genetics of the ASCR, Prague, Czech Republic
Cancer Science Institute, National University of Singapore, Singapore
Harvard Stem Cell Institute, Harvard Medical School, Boston, MA, USA
Cancer Science Institute, National University of Singapore, Singapore
Cancer Science Institute, National University of Singapore, Singapore
Institute of Molecular Genetics of the ASCR, Prague, Czech Republic
Erasmus University Medical Center, Rotterdam, the Netherlands
Institute of Molecular Genetics of the ASCR, Prague, Czech Republic
Cancer Science Institute, National University of Singapore, Singapore;Cancer and Stem Cell Biology Program, Duke–National University of Singapore (NUS) Graduate Medical School;Genome Institute of Singapore, Singapore
Cancer Science Institute, National University of Singapore, Singapore;Harvard Stem Cell Institute, Harvard Medical School, Boston, MA, USA
Institute of Molecular Genetics of the ASCR, Prague, Czech Republic;Harvard Stem Cell Institute, Harvard Medical School, Boston, MA, USA
Vol. 99 No. 4 (2014): April, 2014 https://doi.org/10.3324/haematol.2013.093278